
Leading the next phase of European CDMO: A conversation with Suanfarma’s CEO
When we last spoke with Suanfarma in 2023, the focus was on a company expanding its footprint. At the time that meant strengthening its API manufacturing base, growing internationally, and building on its dual expertise in pharmaceuticals and nutraceuticals. In 2026, the…








